SynBiotic SE
Research SynBiotic SE (SBX) on Bullrun: market cap EUR 4.55M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerSBX
- ExchangeXETRA
- CountryGermany
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyEUR
- Market capEUR 4.55M
- Financial periodFY2024
- RevenueEUR 14.31M
- Revenue growth270.5%
- Net income-EUR 9.72M
- Free cash flow-EUR 726.07K
- Gross margin34.0%
Valuation Snapshot
latest market cap is EUR 4.55M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2024 | EUR 14.31M | -EUR 9.72M | -EUR 726.07K | 34.0% | -1.66 | EUR 543.17K | EUR 5.51M | EUR 22.87M |
| FY2023 | EUR 3.86M | -EUR 10.63M | -EUR 2.94M | 39.0% | -2.24 | EUR 89.21K | EUR 3.68M | EUR 15.79M |
| FY2022 | EUR 8.17M | -EUR 24.36M | -EUR 7.47M | 43.7% | -5.97 | EUR 966.56K | EUR 4.45M | EUR 22.59M |
| FY2021 | EUR 8.65M | -EUR 12.72M | -EUR 5.51M | 55.3% | -4.09 | EUR 3.20M | EUR 3.43M | EUR 35.00M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-29 | EUR 4.55M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 EUR.
About SynBiotic SE
SynBiotic SE, together with its subsidiaries, engages in the pharmaceutical business in Germany and Europe. It is involved in the cultivation, research, development, production, and distribution of medicinal cannabis; industrial hemp; and cannabidiol and cannabinoid-based products. The company was incorporated in 2024 and is based in Düsseldorf, Germany.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is SynBiotic SE's market cap?
SynBiotic SE's market capitalization is EUR 4.55M.
What does SynBiotic SE do?
SynBiotic SE, together with its subsidiaries, engages in the pharmaceutical business in Germany and Europe. It is involved in the cultivation, research, development, production, and distribution of medicinal cannabis; industrial hemp; and cannabidiol and cannabinoid-based products. The company was incorporated in 2024 and is based in Düsseldorf, Germany.